In vivo studies using knockout and overexpression of Btg2 in mice confirm a role for this gene as a tumor suppressor in medulloblastoma (Farioli‐Vecchioli et al., 2007; Farioli‐Vecchioli, Cina, et al., 2012). This evidence concerns the gene BTG2 and neoplasm.